Ncyte® Heart in A Box™
Ncyte® Heart in a Box™ is an innovative 3D cardiac microtissue model derived from human-induced pluripotent stem cells (iPSCs). It integrates three critical cell types—ventricular cardiomyocytes, endothelial cells, and cardiac fibroblasts—into a single, high-purity product that mirrors the complexity of the human heart.
This system provides a more accurate platform for studying heart development, disease modeling, and therapeutic testing.
.png)
Immunofluorescence staining for α-SMA (red), cTnT (yellow), and PECAM (green) showing the presence of key cell types. DAPI (blue) stains nuclei.
- Comprehensive cardiac model
- High purity and functionality
- Supports co-culture applications to study cell interactions within the cardiac microenvironment
- Enables advanced toxicity and drug screening studies
Do you want to buy Ncyte® Heart in a Box™?
Do you need a different cell volume or a custom model?
Product Specifications
Identity markers
vCardiomyocytes: ≥90%cTnT+, Endothelial Cells: ≥90% CD31+/CD144+, Cardiac Fibroblasts: ≥95% vimentin+/≥85% TCF21, Thawing according to user guide
Format
Cryopreserved cells
Size (viable cells/vial)
vCardiomyocytes: ≥4M viable cells, Endothelial Cells: ≥1M viable cells, Cardiac Fibroblasts: ≥ 0.4M cells viable cells, Thawing cells according user guide
Quality Control
Cell count, Viability, Identity (FACS, ICC), Mycoplasma testing
Donor
Female
Reprogramming method
Ectopic expression of reprogramming factors using episomal plasmids
Shipping conditions
Dry shipper, -180C to -135C
Storage conditions
Vapor phase of liquid nitrogen
Technical Data
Learn more about Ncyte® Heart in a Box™ by downloading the fact sheet
Cardiotoxicity Testing and Drug Screening
Ncyte® Heart in a Box™ offers a comprehensive platform for assessing the cardiotoxic effects of potential drug candidates. By incorporating cardiomyocytes, endothelial cells, and cardiac fibroblasts, this system allows researchers to evaluate drug effects on cardiac function, viability, and toxicity across various heart cell types. High-throughput screening and large-scale compound testing can predict cardiotoxicity risks before clinical trials, reducing the reliance on animal models.



Heart Disease Modeling
This system is ideal for modelling various
cardiovascular diseases, including ischemic
heart disease, heart failure, hypertrophy, and
fibrosis. Researchers can explore disease
mechanisms in a human-relevant 3D envi-
ronment, gaining a deeper understanding of
cellular interactions and disease progression.
Ncyte® Heart in a Box™ is particularly useful
for studying how cardiomyocytes, endothelial
cells, and fibroblasts interact during heart
disease development.
.png)
Angiogenesis and Vascular Remodeling
Ncyte® Endothelial Cells form functional
vascular networks, providing an excellent
model for studying angiogenesis and vascular
remodelling, especially in ischemic heart
diseases. This application is valuable for
testing therapies aimed at promoting blood
vessel growth and improving circulation,
such as in post-myocardial infarction or
heart failure.
.png)
Fibrosis Research and ECM Remodeling
Cardiac fibrosis, a hallmark of many heart
diseases, is driven by the activation of car-
diac fibroblasts. Ncyte® Cardiac Fibroblasts
offer a unique opportunity to study ECM re-
modelling, collagen deposition, and fibroblast
activation in response to injury. This system
is critical for developing antifibrotic therapies
to reduce scar tissue formation and restore
heart function.

.png)
.png)
Certificates of analysis are available upon request via support@ncardia.com
Our work centers on a simple yet powerful premise:
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.

Human iPSC-derived atrial cardiomyocytes
Neural
Human iPSC-derived astrocytes
Vascular
Human iPSC-derived vascular endothelial cells
Cardiac.png)
Human iPSC-derived 3D cardiac microtissue model
Neural
Human iPSC-derived microglia
Vascular
Human iPSC-derived vascular smooth muscle cells
Cardiac
Human iPSC-derived ventricular cardiomyocytes